| ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
| 49402 | BXB2_BOMMO | P26734 | BBXB2 | Bombyxin B-2; BBX-B2; 4K-prothoracicotropic hormone; 4K-PTTH | 100169721 |
| 49401 | BXB1_SAMCY | P33721 | SBXB1 | Bombyxin B-1 homolog | 0 |
| 49400 | BXB1_BOMMO | P26733 | BBXB1 | Bombyxin B-1; BBX-B1; 4K-prothoracicotropic hormone; 4K-PTTH | 100169719 |
| 49399 | BXB12_BOMMO | P29519 | BBXB12 | Bombyxin B-12; BBX-B12; 4K-prothoracicotropic hormone; 4K-PTTH | 100169722 |
| 49398 | BXB11_BOMMO | Q17196 | BBXB11 | Bombyxin B-11; BBX-B11; 4K-prothoracicotropic hormone; 4K-PTTH | 100169656 |
| 49397 | BXB10_BOMMO | Q17194 | BBXB10 | Bombyxin B-10; BBX-B10; 4K-prothoracicotropic hormone; 4K-PTTH | 100169715 |
| 49396 | BXAN_CLOBO | Q45914 | ant | Non-toxic nonhemagglutinin type A; NTNHA; Botulinum neurotoxin type A non-toxic component | 5185060 |
| 49395 | BXA9_BOMMO | P07230; P26732 | BBXA9 | Bombyxin A-9; BBX-A9; 4K-prothoracicotropic hormone; 4K-PTTH | 100169658 |
| 49394 | BXA8_BOMMO | P26731 | BBXA8 | Bombyxin A-8; BBX-A8; 4K-prothoracicotropic hormone; 4K-PTTH | 100169709 |
| 49393 | BXA7_BOMMO | P07230; P26730 | BBXA7 | Bombyxin A-7; BBX-A7; 4K-prothoracicotropic hormone; 4K-PTTH | 100169708 |
| 49392 | BXA6_BOMMO | P07230; P26729 | BBXA6 | Bombyxin A-6; BBX-A6; 4K-prothoracicotropic hormone; 4K-PTTH; Bombyxin-II | 0 |
| 49391 | BXA5_BOMMO | P26728 | BBXA5 | Bombyxin A-5; BBX-A5; 4K-prothoracicotropic hormone; 4K-PTTH | 100169658 |
| 49390 | BXA4_BOMMO | P26727 | BBXA4 | Bombyxin A-4; BBX-A4; 4K-prothoracicotropic hormone; 4K-PTTH | 100169657 |
| 49389 | BXA3_SAMCY | P33720 | SBXA3 | Bombyxin A-3 homolog | 0 |
| 49388 | BXA3_BOMMO | P26726 | BBXA3 | Bombyxin A-3; BBX-A3; 4K-prothoracicotropic hormone; 4K-PTTH | 100169712 |
| 49387 | BXA2_SAMCY | P33719 | SBXA2 | Bombyxin A-2 homolog | 0 |
| 49386 | BXA2_CLOBJ | C1FUH9; P77780; Q45894 | botA {ECO:0000303|Ref.2} | Botulinum neurotoxin type A2; BoNT/A; Bontoxilysin-A {ECO:0000303|Ref.2}; BOTOX; LC; 3.4.24.69 {ECO:0000269|PubMed:16846233}; HC | 0 |
| 49385 | BXA2_BOMMO | P15411 | BBXA2 | Bombyxin A-2; BBX-A2; 4K-prothoracicotropic hormone; 4K-PTTH | 693012 |
| 49384 | BXA1_SAMCY | P33718 | SBXA1 | Bombyxin A-1 homolog | 0 |
| 49383 | BXA1_CLOBO | A5HZZ9; A7G1U9; P01561; P0DPI0; P10845; P18639 | botA {ECO:0000303|PubMed:2185020} | Botulinum neurotoxin type A; BoNT/A; Bontoxilysin-A; BOTOX; Botulinum neurotoxin type A1; LC; 3.4.24.69 {ECO:0000269|PubMed:8243676}; HC | 5185061 |
| 49382 | BXA1_CLOBH | A5HZZ9; A7G1U9; P01561; P0DPI1; P10845; P18639 | botA {ECO:0000303|PubMed:17519437} | Botulinum neurotoxin type A; BoNT/A; Bontoxilysin-A; BOTOX; LC; 3.4.24.69 {ECO:0000269|PubMed:8103915}; HC | 5185061 |
| 49381 | BXA1_BOMMO | Q17192 | BBXA1 | Bombyxin A-1; BBX-A1; 4K-prothoracicotropic hormone; 4K-PTTH | 101736783 |
| 49380 | BX9_MAIZE | B4G072; Q8W2B6 | BX9 | DIMBOA UDP-glucosyltransferase BX9; 2.4.1.202 {ECO:0000269|PubMed:11851909, ECO:0000269|PubMed:16666853}; 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-D-glucosyltransferase BX9; Protein BENZOXAZINLESS 9 | 100274317 |
| 49379 | BX8_MAIZE | Q8W2B7 | Bx8 | DIMBOA UDP-glucosyltransferase BX8; 2.4.1.202 {ECO:0000269|PubMed:11851909, ECO:0000269|PubMed:16666853}; 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-D-glucosyltransferase BX8; Protein BENZOXAZINLESS 8 | 0 |
| 49378 | BX8_LOXGA | P0C2K9 | | Dermonecrotic toxin LgSicTox-beta-LOXN8; 4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2}; Phospholipase D; PLD; Sphingomyelin phosphodiesterase D; SMD; SMase D; Sphingomyelinase D | 0 |
| 49377 | BX7_MAIZE | B1P123 | BX7 | TRIBOA-glucoside O-methyltransferase BX7; 2.1.1.241; 2,4,7-trihydroxy-1,4-benzoxazin-3-one-glucoside 7-O-methyltransferase; Protein BENZOXAZINONE SYNTHESIS 7 | 100147731 |
| 49376 | BX6_MAIZE | Q84TC2 | BX6 | DIBOA-glucoside dioxygenase BX6; 1.14.11.59 {ECO:0000269|PubMed:18192444}; 2,4-dihydroxy-1,4-benzoxazin-3-one-glucoside dioxygenase; 2-oxoglutarate-dependent dioxygenase BX6; Protein BENZOXAZINONE SYNTHESIS 6 | 541977 |
| 49375 | BX4_LOXGA | P0C2K6 | | Dermonecrotic toxin LgSicTox-beta-LOXN4; 4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2}; Phospholipase D; PLD; Sphingomyelin phosphodiesterase D; SMD; SMase D; Sphingomyelinase D | 0 |
| 49374 | BX42_DROME | P39736; Q9W390 | Bx42 | Puff-specific protein Bx42 | 31840 |
| 49373 | BX3_LOXGA | P0C2K5 | | Dermonecrotic toxin LgSicTox-beta-LOXN3; 4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2}; Phospholipase D; PLD; Sphingomyelin phosphodiesterase D; SMD; SMase D; Sphingomyelinase D | 0 |
| 49372 | BX2_LOXGA | P0C2K4 | | Dermonecrotic toxin LgSicTox-beta-LOXN2; 4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2}; Phospholipase D; PLD; Sphingomyelin phosphodiesterase D; SMD; SMase D; Sphingomyelinase D | 0 |
| 49371 | BX17_LOXGA | P0C2K3 | | Dermonecrotic toxin LgSicTox-beta-LOXN1/LOXN7; 4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2}; Phospholipase D; PLD; Sphingomyelin phosphodiesterase D; SMD; SMase D; Sphingomyelinase D | 0 |
| 49370 | BWR1B_HUMAN | E9PLK8; O43563; Q8N1D0 | SLC22A18AS | Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein; Organic cation transporter-like protein 2 antisense protein; Solute carrier family 22 member 1-like antisense protein; Solute carrier family 22 member 18 antisense protein; p27-Beckwith-Wiedemann region 1 B; p27-BWR1B | 5003 |
| 49369 | BWNIN_PONAB | Q5RDZ8 | BRAWNIN {ECO:0000250|UniProtKB:Q69YU5} | Protein BRAWNIN {ECO:0000250|UniProtKB:Q69YU5} | 100171825 |
| 49368 | BWNIN_MOUSE | Q8BTC1 | Brawnin {ECO:0000303|PubMed:32161263} | Protein BRAWNIN {ECO:0000303|PubMed:32161263} | 544717 |
| 49367 | BWNIN_HUMAN | Q69YU5 | BRAWNIN {ECO:0000303|PubMed:32161263} | Protein BRAWNIN {ECO:0000303|PubMed:32161263} | 728568 |
| 49366 | BWNIN_DANRE | E7EXZ6 | brawnin {ECO:0000303|PubMed:32161263} | Protein brawnin {ECO:0000303|PubMed:32161263} | 100190888 |
| 49365 | BVMO_PSEPK | Q88J44 | | Baeyer-Villiger monooxygenase {ECO:0000303|PubMed:17530181}; BVMO {ECO:0000303|PubMed:17530181}; 1.14.13.- {ECO:0000269|PubMed:17530181} | 0 |
| 49364 | BVMO_PSEBH | A3U3H1 | | Baeyer-Villiger monooxygenase {ECO:0000303|PubMed:24903773}; BVMO {ECO:0000305}; 1.14.13.- {ECO:0000269|PubMed:24903773} | 0 |
| 49363 | BVMO_PSEAE | Q9I3H5 | | Baeyer-Villiger monooxygenase {ECO:0000303|PubMed:18051317}; BVMO {ECO:0000303|PubMed:18051317}; 1.14.13.- {ECO:0000269|PubMed:18051317} | 880860 |
| 49362 | BVMO_PARL1 | A7HU16 | | Baeyer-Villiger monooxygenase {ECO:0000303|PubMed:24903773}; BVMO {ECO:0000305}; 1.14.13.- {ECO:0000269|PubMed:24903773} | 0 |
| 49361 | BVMO4_DIESD | U5S003 | | Baeyer-Villiger monooxygenase 4 {ECO:0000303|PubMed:24949258}; BVMO4 {ECO:0000303|PubMed:24949258}; 1.14.13.- {ECO:0000269|PubMed:24949258} | 0 |
| 49360 | BVMO2_STRCO | Q9RKB5 | | Baeyer-Villiger monooxygenase {ECO:0000303|PubMed:18051317}; BVMO {ECO:0000303|PubMed:18051317}; 1.14.13.- {ECO:0000269|PubMed:18051317} | 1098606 |
| 49359 | BVMO1_STRCO | Q9RL17 | | Baeyer-Villiger monooxygenase {ECO:0000303|PubMed:18051317}; BVMO {ECO:0000303|PubMed:18051317}; 1.14.13.- {ECO:0000269|PubMed:18051317} | 1095724 |
| 49358 | BVGS_BORPE | P16575; P16576 | bvgS | Virulence sensor protein BvgS; 2.7.13.3 | 0 |
| 49357 | BVGS_BORPA | P40330 | bvgS | Virulence sensor protein BvgS; 2.7.13.3 | 0 |
| 49356 | BVGS_BORBR | P26762 | bvgS | Virulence sensor protein BvgS; 2.7.13.3 | 0 |
| 49355 | BVGA_BORPE | P0A4H2; P16574 | bvgA | Virulence factors putative positive transcription regulator BvgA | 56479102 |
| 49354 | BVGA_BORPA | P0A4H4; P16574 | bvgA | Virulence factors putative positive transcription regulator BvgA | 56479102 |
| 49353 | BVGA_BORBR | P0A4H3; P16574 | bvgA | Virulence factors putative positive transcription regulator BvgA | 56479102 |
